BSE Live
Dec 29, 16:01Prev. Close
1101.45
Open Price
1101.45
Bid Price (Qty.)
1136.30 (192)
Offer Price (Qty.)
1150.00 (4)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 10.38 | 10.38 | 10.38 | 5.19 | 5.01 | |
| Total Share Capital | 10.38 | 10.38 | 10.38 | 5.19 | 5.01 | |
| Reserves and Surplus | 35.92 | 27.49 | 19.94 | 20.45 | 16.76 | |
| Total Reserves and Surplus | 36.72 | 28.29 | 20.74 | 21.25 | 17.56 | |
| Total Shareholders Funds | 47.09 | 38.66 | 31.12 | 26.44 | 22.56 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 10.18 | 7.01 | 4.11 | 3.13 | 2.53 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.12 | 0.21 | 0.40 | 0.45 | |
| Other Long Term Liabilities | 9.18 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.62 | 0.52 | 0.55 | 0.54 | 0.17 | |
| Total Non-Current Liabilities | 19.98 | 7.66 | 4.87 | 4.07 | 3.15 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 21.24 | 18.73 | 21.33 | 15.09 | 9.65 | |
| Trade Payables | 22.97 | 17.07 | 21.89 | 12.74 | 9.67 | |
| Other Current Liabilities | 20.40 | 21.57 | 15.88 | 11.39 | 5.94 | |
| Short Term Provisions | 3.00 | 3.30 | 2.60 | 2.30 | 1.28 | |
| Total Current Liabilities | 67.61 | 60.67 | 61.70 | 41.52 | 26.54 | |
| Total Capital And Liabilities | 134.68 | 106.99 | 97.69 | 72.03 | 52.26 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 41.63 | 28.02 | 19.27 | 15.77 | 11.35 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 41.63 | 28.02 | 19.27 | 15.77 | 11.35 | |
| Non-Current Investments | 4.20 | 4.64 | 4.11 | 3.73 | 2.77 | |
| Deferred Tax Assets [Net] | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | |
| Other Non-Current Assets | 0.00 | 0.03 | 0.07 | 0.10 | 0.14 | |
| Total Non-Current Assets | 46.15 | 32.82 | 23.57 | 19.73 | 14.38 | |
| CURRENT ASSETS | ||||||
| Current Investments | 3.34 | 3.82 | 4.43 | 2.94 | 1.91 | |
| Inventories | 22.42 | 11.24 | 14.93 | 13.74 | 8.63 | |
| Trade Receivables | 30.35 | 38.75 | 37.16 | 22.70 | 19.79 | |
| Cash And Cash Equivalents | 1.15 | 0.28 | 1.03 | 2.36 | 1.00 | |
| Short Term Loans And Advances | 31.25 | 20.05 | 16.53 | 10.54 | 6.51 | |
| OtherCurrentAssets | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Total Current Assets | 88.53 | 74.17 | 74.12 | 52.31 | 37.87 | |
| Total Assets | 134.68 | 106.99 | 97.69 | 72.03 | 52.26 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1.27 | 5.29 | 2.83 | 2.30 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 10.50 | 7.59 | 4.49 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 1.34 | 0.86 | 0.19 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 3.09 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 78.82 | 83.57 | 56.17 | 35.65 | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.68 | 5.68 | 5.68 | 0.50 | 0.50 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 4.20 | 4.64 | 4.11 | 3.73 | 2.77 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 3.34 | 3.82 | 4.43 | 2.94 | 1.91 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y